Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1216 AL 1230

A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease

Au KLK, Lopes JLMLJ, Kraus A, Patton K, Warren L, Gao H, Wong JK, Moore K, Toledo JB, Stiep T, Frey J, Tholanikunnel T, Hess C, Almeida L, Ramirez-Zamora A, Okun MS.

Parkinsonism Relat Disord. 2022 Apr;97:57-62. doi: 10.1016/j.parkreldis.2022.02.021. Epub 2022 Mar 10.

HDL Accessory Proteins in Parkinson's Disease-Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics-A Review

Berdowska I, Matusiewicz M, Krzystek-Korpacka M.

Antioxidants (Basel). 2022 Mar 9;11(3):524. doi: 10.3390/antiox11030524.

Ginkgo biloba in the Aging Process: A Narrative Review

Barbalho SM, Direito R, Laurindo LF, Marton LT, Guiguer EL, Goulart RA, Tofano RJ, Carvalho ACA, Flato UAP, Capelluppi Tofano VA, Detregiachi CRP, Bueno PCS, Girio RSJ, Araújo AC.

Antioxidants (Basel). 2022 Mar 9;11(3):525. doi: 10.3390/antiox11030525.

Brain Connectivity and Graph Theory Analysis in Alzheimer's and Parkinson's Disease: The Contribution of Electrophysiological Techniques

Miraglia F, Vecchio F, Pappalettera C, Nucci L, Cotelli M, Judica E, Ferreri F, Rossini PM.

Brain Sci. 2022 Mar 18;12(3):402. doi: 10.3390/brainsci12030402.

Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson's Disease

Murros KE.

Cells. 2022 Mar 12;11(6):978. doi: 10.3390/cells11060978.

Pathophysiology and Symptomatology of Drooling in Parkinson's Disease

Polychronis S, Nasios G, Dardiotis E, Messinis L, Pagano G.

Healthcare (Basel). 2022 Mar 11;10(3):516. doi: 10.3390/healthcare10030516.

Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases

Chiang MH, Ho SM, Wu HY, Lin YC, Tsai WH, Wu T, Lai CH, Wu CL.

Biomedicines. 2022 Mar 3;10(3):596. doi: 10.3390/biomedicines10030596.

Shared Molecular Targets in Parkinson's Disease and Arterial Hypertension: A Systematic Review

Tulbă D, Avasilichioaei M, Dima N, Crăciun L, Bălănescu P, Buzea A, Băicuș C, Popescu BO.

Biomedicines. 2022 Mar 11;10(3):653. doi: 10.3390/biomedicines10030653.

Leukotriene Signaling as a Target in α-Synucleinopathies

Strempfl K, Unger MS, Flunkert S, Trost A, Reitsamer HA, Hutter-Paier B, Aigner L.

Biomolecules. 2022 Feb 23;12(3):346. doi: 10.3390/biom12030346.

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age

Payne A, Nahashon S, Taka E, Adinew GM, Soliman KFA.

Biomolecules. 2022 Feb 25;12(3):371. doi: 10.3390/biom12030371.

Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology

Van Schoor E, Vandenbulcke M, Bercier V, Vandenberghe R, van der Zee J, Van Broeckhoven C, Otto M, Hanseeuw B, Van Damme P, Van Den Bosch L, Thal DR.

Biomolecules. 2022 Mar 12;12(3):440. doi: 10.3390/biom12030440.

Endogenous Human Proteins Interfering with Amyloid Formation

Gharibyan AL, Wasana Jayaweera S, Lehmann M, Anan I, Olofsson A.

Biomolecules. 2022 Mar 14;12(3):446. doi: 10.3390/biom12030446.

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

Roy B, Lee E, Li T, Rampersaud M.

Genes (Basel). 2022 Feb 25;13(3):425. doi: 10.3390/genes13030425.

Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing

Jia F, Fellner A, Kumar KR.

Genes (Basel). 2022 Mar 7;13(3):471. doi: 10.3390/genes13030471.

Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?

Lanore A, Lesage S, Mariani LL, Menon PJ, Ravassard P, Cheval H, Corti O, Brice A, Corvol JC.

Genes (Basel). 2022 Mar 8;13(3):479. doi: 10.3390/genes13030479.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias